UB Paderborn / Katalog / Suche / in CDI

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

European heart journal, 2015-09, Vol.36 (33), p.2239-2245

2015

Link zum Volltext

Verfügbarkeit prüfen

Is there a role for half-dose anticoagulation in atrial fibrillation? Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Link zum Volltext

Verfügbarkeit prüfen

P3605The usefulness of the TIMI-AF score in the prediction of ischemic stroke and bleeding for Asian patients with atrial fibrillation

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Link zum Volltext

Verfügbarkeit prüfen

Triple Therapy: Aspirin, Thienopyridine and Oral Anticoagulation Therapy Following STEMI: Is it Safe?

Heart, lung & circulation, 2009, Vol.18, p.S128-S128

2009

Link zum Volltext

Verfügbarkeit prüfen

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

European heart journal, 2002-02, Vol.23 (3), p.223-229

2002

Link zum Volltext

Verfügbarkeit prüfen

Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE

European heart journal, 2002-02, Vol.23 (4), p.308-314

2002

Link zum Volltext

Verfügbarkeit prüfen

Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14

European heart journal, 2000-12, Vol.21 (23), p.1944-1953

2000

Link zum Volltext

Verfügbarkeit prüfen

Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II

European heart journal, 2001-09, Vol.22 (18), p.1702-1715

2001

Link zum Volltext

Verfügbarkeit prüfen

Maladie coronaire

Archives des maladies du coeur et des vaisseaux. Pratique, 2009-11, Vol.2009 (182), p.45-46

2009

Link zum Volltext

Verfügbarkeit prüfen

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II

European heart journal, 2002-06, Vol.23 (12), p.928-933

2002

Link zum Volltext

Verfügbarkeit prüfen

Foreword

European heart journal supplements, 2001-08, Vol.3 (suppl-J), p.J1-J5

2001

Link zum Volltext

Verfügbarkeit prüfen

Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction

European heart journal, 2001-11, Vol.22 (22), p.2104-2115

2001

Link zum Volltext

Verfügbarkeit prüfen

Caeteris paribus—all things being equal

European heart journal, 2001-12, Vol.22 (24), p.2221-2223

2001

Link zum Volltext

Verfügbarkeit prüfen

Cardiac marker elevation after cardioversion: sorting out chicken and egg

European heart journal, 2000-02, Vol.21 (3), p.171-173

2000

Link zum Volltext

Verfügbarkeit prüfen

Managing ST elevation myocardial infarction

European heart journal supplements, 2002-05, Vol.4 (suppl_E), p.E15-E23

2002

Link zum Volltext

Verfügbarkeit prüfen

Critical pathway for acute ST segment elevation myocardial infarction: evaluation of the potential impact in the TIMI 9 registry

Journal of the American College of Cardiology, 1998, Vol.31, p.192-192

1998

Link zum Volltext

Verfügbarkeit prüfen

Issues in early risk stratification for UA/NSTEMI

European heart journal supplements, 2001-08, Vol.3 (suppl-J), p.J6-J14

2001

Link zum Volltext

Verfügbarkeit prüfen

Managing ST elevation myocardial infarction

European heart journal supplements, 2002-05, Vol.4 (suppl-E), p.E15-E23

2002

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of cardiac myosin light chains in acute ischemic syndromes - results from TIMI 3B

Journal of the American College of Cardiology, 1998-02, Vol.31, p.380-380

1998

Link zum Volltext

Verfügbarkeit prüfen

Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trials

Journal of the American College of Cardiology, 1998, Vol.31, p.191-191

1998

Link zum Volltext

Verfügbarkeit prüfen

Amiodarone therapy and autoimmune thyroid disease: Increase in a new monoclonal antibody-defined T cell subset

The American journal of medicine, 1986-07, Vol.81 (1), p.53-57

1986

Link zum Volltext

Verfügbarkeit prüfen

Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-thrombolysis in myocardial infarction (TIMI) 23 trial

ACC current journal review, 2002-09, Vol.11 (5), p.15-15

2002

Link zum Volltext

Verfügbarkeit prüfen

A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy

ACC current journal review, 2002-03, Vol.11 (2), p.14-14

2002

Link zum Volltext

Verfügbarkeit prüfen

Application of the TIMI risk score for ST-elevation MI in the national registry of myocardial infarction 3

ACC current journal review, 2002, Vol.11 (1), p.13-13

2002

Link zum Volltext

Verfügbarkeit prüfen

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

ACC current journal review, 2001-05, Vol.10 (3), p.16-16

2001

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

Is there a role for half-dose anticoagulation in atrial fibrillation? Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48

P3605The usefulness of the TIMI-AF score in the prediction of ischemic stroke and bleeding for Asian patients with atrial fibrillation

Triple Therapy: Aspirin, Thienopyridine and Oral Anticoagulation Therapy Following STEMI: Is it Safe?

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE

Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14

Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II

Maladie coronaire

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II

Foreword

Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction

Caeteris paribus—all things being equal

Cardiac marker elevation after cardioversion: sorting out chicken and egg

Managing ST elevation myocardial infarction

Critical pathway for acute ST segment elevation myocardial infarction: evaluation of the potential impact in the TIMI 9 registry

Issues in early risk stratification for UA/NSTEMI

Managing ST elevation myocardial infarction

The prognostic value of cardiac myosin light chains in acute ischemic syndromes - results from TIMI 3B

Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trials

Amiodarone therapy and autoimmune thyroid disease: Increase in a new monoclonal antibody-defined T cell subset

Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-thrombolysis in myocardial infarction (TIMI) 23 trial

A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy

Application of the TIMI risk score for ST-elevation MI in the national registry of myocardial infarction 3

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

Suchergebnisse filtern